Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151


M-HIFU inhibits tumor growth, suppresses STAT3 activity and enhances tumor specific immunity in a transplant tumor model of prostate cancer.

Huang X, Yuan F, Liang M, Lo HW, Shinohara ML, Robertson C, Zhong P.

PLoS One. 2012;7(7):e41632. doi: 10.1371/journal.pone.0041632.


Investigation of HIFU-induced anti-tumor immunity in a murine tumor model.

Hu Z, Yang XY, Liu Y, Sankin GN, Pua EC, Morse MA, Lyerly HK, Clay TM, Zhong P.

J Transl Med. 2007 Jul 11;5:34.


High-intensity focused ultrasound tumor ablation activates autologous tumor-specific cytotoxic T lymphocytes.

Xia JZ, Xie FL, Ran LF, Xie XP, Fan YM, Wu F.

Ultrasound Med Biol. 2012 Aug;38(8):1363-71. doi: 10.1016/j.ultrasmedbio.2012.03.009.


Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound.

Zhang Y, Deng J, Feng J, Wu F.

World J Gastroenterol. 2010 Jul 28;16(28):3584-91.


Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI-124 in a mouse melanoma tumor model.

Molavi O, Ma Z, Hamdy S, Lai R, Lavasanifar A, Samuel J.

Immunol Cell Biol. 2008 Aug-Sep;86(6):506-14. doi: 10.1038/icb.2008.27.


Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes.

He XZ, Wang QF, Han S, Wang HQ, Ye YY, Zhu ZY, Zhang SZ.

Drug Des Devel Ther. 2015 Mar 10;9:1449-58. doi: 10.2147/DDDT.S76592.


Combination immunotherapy and active-specific tumor cell vaccination augments anti-cancer immunity in a mouse model of gastric cancer.

van den Engel NK, Rüttinger D, Rusan M, Kammerer R, Zimmermann W, Hatz RA, Winter H.

J Transl Med. 2011 Aug 22;9:140. doi: 10.1186/1479-5876-9-140.


Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.

Tuomela JM, Valta MP, Väänänen K, Härkönen PL.

BMC Cancer. 2008 Mar 28;8:81. doi: 10.1186/1471-2407-8-81.


[High-intensity focused ultrasound inhibits tumor metastasis in a melanoma-bearing mouse model].

Li H, Yuan S, Yang M, Duan L, Wang H, Zha H, Li X, Sun H, Weng Y, Luo J, He T, Li C, Wang Y, Li F, Wang Z, Zhou L.

Nan Fang Yi Ke Da Xue Xue Bao. 2015 Feb;35(2):223-8. Chinese.


Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models.

Shen L, Ciesielski M, Ramakrishnan S, Miles KM, Ellis L, Sotomayor P, Shrikant P, Fenstermaker R, Pili R.

PLoS One. 2012;7(1):e30815. doi: 10.1371/journal.pone.0030815.


Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.

Bjorge JD, Pang AS, Funnell M, Chen KY, Diaz R, Magliocco AM, Fujita DJ.

PLoS One. 2011 Apr 26;6(4):e19309. doi: 10.1371/journal.pone.0019309.


Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.

Viehl CT, Moore TT, Liyanage UK, Frey DM, Ehlers JP, Eberlein TJ, Goedegebuure PS, Linehan DC.

Ann Surg Oncol. 2006 Sep;13(9):1252-8.


Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.

Ohshio Y, Teramoto K, Hanaoka J, Tezuka N, Itoh Y, Asai T, Daigo Y, Ogasawara K.

Cancer Sci. 2015 Feb;106(2):134-42. doi: 10.1111/cas.12584.


Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth.

Zhang L, Gao L, Li Y, Lin G, Shao Y, Ji K, Yu H, Hu J, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ.

Clin Cancer Res. 2008 Jan 15;14(2):559-68. doi: 10.1158/1078-0432.CCR-07-1176.


Activation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearing mice.

Ahmad F, Mani J, Kumar P, Haridas S, Upadhyay P, Bhaskar S.

PLoS One. 2011;6(9):e25424. doi: 10.1371/journal.pone.0025424.


Transforming growth factor-beta-mediated signaling in T lymphocytes impacts on prostate-specific immunity and early prostate tumor progression.

Diener KR, Woods AE, Manavis J, Brown MP, Hayball JD.

Lab Invest. 2009 Feb;89(2):142-51. doi: 10.1038/labinvest.2008.123.


Dendritic cells loaded with ultrasound-ablated tumour induce in vivo specific antitumour immune responses.

Deng J, Zhang Y, Feng J, Wu F.

Ultrasound Med Biol. 2010 Mar;36(3):441-8. doi: 10.1016/j.ultrasmedbio.2009.12.004.


Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines.

Barton BE, Murphy TF, Shu P, Huang HF, Meyenhofer M, Barton A.

Mol Cancer Ther. 2004 Oct;3(10):1183-91. Erratum in: Mol Cancer Ther. 2004 Dec;3(12):1701. Meyenhofen, Marcus [corrected to Meyenhofer, Markus].

Items per page

Supplemental Content

Support Center